CSULB5.3.04 Effects of M1G1 on the systemic dissemination of Candida albicans By David Nguyen Mentor: Dr. Zhang.

Slides:



Advertisements
Similar presentations
1 Workshop on the immunological basis of vaccine efficacy Vaccine and Infectious Disease Institute December 14, 2009 Ira M. Longini, Jr. Center for Statistical.
Advertisements

OPPORTUNISTIC FUNGAL INFECTIONS
Fungal Diseases March 24 th, Fungi fundamentals Occupy almost every ecological niche Exist in two forms: Yeasts –Single celled Molds –Growth in.
Fundamental Medical Mycology Fungal Characteristics Fungal Classification Fungal Terminology www. mycology.adelaide.edu.au/Fungal_Jungle/kaminski.html.
Infectious Diseases/ Immune System. NOTES Infectious Disease= caused by pathogens that enter, live in/on, and multiply within the human body. Pathogens=
Production of Monoclonal Antibodies Jose Baeza California State University, Long Beach Mentor: Dr. Zhang.
It’s safety and I know it!. The Chain of Infection.
Methods to Study and Control Diseases in Wild Populations Steve Bellan, MPH Department of Environmental Sci, Pol & Mgmt University of California at Berkeley.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
HIV/AIDS Isabelle Récaborde Dr. Frigon Chemistry SL – Block F Option - Medicine and Drugs.
Lesson 4 Treatment for HIV / AIDS
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPACT) Group PROMISE (BREAST FEEDING) 1077 AAHU STC 2013 Group 2 Cedric Sturdevant,
Infections of the GI Tract November 19, 2007 NCDD Meeting Chair: Mitchell B. Cohen, MD Vice Chair: Richard S. Blumberg, MD.
Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.
MICROBIOLOGY JEOPARDY Third Nine Weeks 2014 ElDoradoHighSchoolAZTECS
MEDICAL TESTING Doctor requires information Patient sample collection
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Danilo Saniatan R.N Charge Nurse RAC-Khurais Clinic.
Microbial Interactions with Humans Basic Definitions Ecological Interactions Normal Microbiota Infectious Diseases Disease = any change in state of health.
Helicobacter pylori Vaccine Development Catherine O. Johnson March 9, 2006.
The study of Pathogens causing Community Acquired Pneumonia in hematological malignancy patients comparing to general patients who hospitalized in Naresuan.
After a virus becomes active and replicates in a host cell, it destroys the host cell. Copies of the virus are then released into the host organism, where.
1 An Interim Monitoring Approach for a Small Sample Size Incidence Density Problem By: Shane Rosanbalm Co-author: Dennis Wallace.
CNS INFECTION Prepare by :Abeer AL-sayeg Prepare by :Abeer AL-sayeg.
INTRODUCTION TO MEDICAL MYCOLOGY
Medical Mycology. Mycology Study of fungi Study of fungi Fungi found every where Fungi found every where.
Immune System Part II Physiology Standards: 10 a-e
Click to edit Master subtitle style 5/9/10 IMMUNOLOGY LAB.
Lesson 1 Reading Guide - Vocab
Detection, Prophylaxis and Treatment of Bacterial Infection.
Characterization of the interaction between Candida albicans and probiotic bacteria or, How do probiotics affect yeast infections? or, Presented by: Kerry.
Basic Mycology (2) Fungal infections form granulomata in response to cell-mediated Acute suppuration occurs in some
DIMORPHISM Dimorphic from Greek word: “dis”: twice “morphe”: producing to morphologically distinct types of zoospores Dimorphic fungi: a fungus able to.
BACTERIA AND VIRUSES ANTIBIOTICS AND BACTERIAL RESISTANCE TO 1.
“ The Effects of Oral Contraceptives on Female Athletes’ Bone Mineral Density” By: Megan Grover and Dr. B. Hamilton Abstract: The initial aim of this research.
$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
Organ Donation & Transplantation EXCI233 Online source: rs/transplantation/overview_of_transplantation.html?qt.
Parasitic Pathogenesis of Toxoplasma gondii Josh Materi Graduating Class of 2015 University of Wyoming.
Risk Factors for Candida dubliniensis Bloodstream Infections Katherine Veltman, B.S., Peggy L. Carver, Pharm.D, FCCP The University of Michigan Health.
1 University of Texas San Antonio Update on F. tularensis attenuated vaccine strain construction and evaluation TVD Team 2/19/08 tech call.
PHARMACEUTICAL MICROBIOLOGY -I PHT 226 Dr. Rasheeda Hamid Abdalla Assistant Professor hotmail.com.
Candida albicans Rebecca A. Drummond, University of Aberdeen, UK
Chapter 10 Bethann Davis MSN,NP Quincy College PNU145 Fall2015
Lesson 4 Treatment for HIV / AIDS
Chapter 22 Infection Control
The association between anti-PcrV titers and protective effects against P. aeruginosa in PcrV vaccinated mice Saeko Hamaoka1, Yoshifumi Naito1, Hideya.
with Dr. Derek Lee, Direct Energy’s Health and Wellness Doctor
Lecturer name: Dr. Ahmed M. Albarraq Lecture Date: Oct.-2013
Effects of Facial Cleaner on E. coli and Staph
Copyright © 2007 American Medical Association. All rights reserved.
MYCOLOGY (MIC 206) DIMORPHISM.
SYSTEMIC POLYMORPHONUCLEAR COUNT
Staten Island University Hospital, Staten Island, New York, USA
Lesson 4 Treatment for HIV / AIDS
Chapter 22 Infection Control
Communicable Diseases
Lab diagnosis of fungal infection
The Emma Barnsley Foundation
Chapter 22 Infection Control
Public Health Surveillance
HIV/AIDS Training for Health Facility Employees
Virus.
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4+ T Cells  Cynthia A Chambers, Timothy J Sullivan,
Volume 46, Issue 6, Pages e4 (June 2017)
NFATc2-deficient mice do not eliminate skin C. albicans infections.
Higher Human Biology Unit 3 – Neurobiology and Immunology
Burton’s Microbiology for the Health Sciences Section I
Belén López-García, Phillip H. A. Lee, Kenshi Yamasaki, Richard L
Objective 2 Biomedical Research Methods
Light microscopic evaluation of bladders and kidneys in E
Presentation transcript:

CSULB Effects of M1G1 on the systemic dissemination of Candida albicans By David Nguyen Mentor: Dr. Zhang

CSULB Background Information Candida albicans is a dimorphic pathogenic yeast known to cause systemic infections within the human population C. albicans is a common saprophyte human commensal, being found in the skin, urogenital, and the alimentary tract Severe C. albicans infections are frequently observed in those whose immune system has been compromised such as advance stage HIV patients

CSULB Background Information Recently, C. albicans, including other Candida species, have become the 4 th leading cause of nosocomial bloodstream infection It has been observed that mortality correlates with the fungal burden of the kidney It has also been noted that viable yeasts can be recovered from kidneys 56 days post-infection, implying that the organism can evade the host’s defenses. This organ’s susceptibility has yet to be elucidated.

CSULB Question Question: How is C. albicans able to evade the host’s defenses 56 days post- infection, especially in the kidneys?

CSULB Hypothesis It is hypothesized that upon infection, before native host antibodies can be produced at an effective protective level, C. albicans can establish itself within the kidney organs. Once the yeasts have been established, the innate immunity is unable to protect the host from the infection and C. albicans colonies will continue to persist in the host.

CSULB Materials and Methods 40 six week old female BALB/c mice

CSULB Materials and Methods Group A (15 mice) are infected and passively immunized Group B (15 mice) are infected and non- passively immunized Group C (10 mice) are non-infected and non-passively immunized

CSULB Materials and Methods 1 mg/mouse recombinant anti-mannan human antibody known as M1G1

CSULB Materials and Methods 1x10 6 cells of C. albicans 3156A (ATCC)

CSULB Materials and Methods Every two weeks, 3 mice from group A, 3 mice from group B, and 2 mice from group C will be euthanized according to institutional regulations from an Association for Assessment and Accreditation of Laboratory Animal Care- Certified (AAALAC-certified) animal facility at California State University Long Beach

CSULB Materials and Methods Organs will be extracted and fixed in 10% formaldehyde. Briefly, each organ from each time frame will be processed via histochemical techniques involving 2 types of stains.

CSULB Materials and Methods First type of stain is known as Hematoxylin and Eosin stain (HE) (detects host cell nuclei)

CSULB Materials and Methods Second type of stain is known as Grocott’s Method for Fungi stain (GMS) (detects fungal matter)

CSULB Materials and Methods Quantitative analysis of the results will be performed using the GMS stains via a calibrated light microscope under 25x. Random areas of cell counts will be taken per 1 mm 2. Qualitative analysis of the results will be performed using the HE stains.

CSULB Materials and Methods Statistics: Analysis of data will be performed using SigmaPlot to analyze the variances of the means of each group as well as correlation analysis.

CSULB Expected Results Expected results of Group A mice should show low amounts of 3153A in the organs due to 3153A being unable to establish itself within organs such as kidneys. Group C should show neither signs of infection and its use will be to account for any artifacts which might show up via the histochemical techniques.

CSULB Expected Results Expected results should show high densities of 3153A at immunologically relevant organs such as kidneys and spleen in Group B mice. There should be observation of extensive growth of yeast hyphae and filaments. Persistant colonies should be observed in the kidneys.

CSULB Expected Results Quantitative determination should indicate a correlation between high and low yeast dissemination in non-passive immunization and passive immunization, respectively. As time progresses, systemic yeast dissemination should be reduced due to the host’s immune system producing its own antibodies against the yeast.

CSULB Expected Results

CSULB Why does it matter? If it is shown that passive immunity can prevent or minimize any detectable traces of C. albicans within the kidneys as well as other organs then this will allow insight into how C. albicans is able to persist within the body many days post-infection.

CSULB Why does it matter? To date no there are no license vaccines for the treatment/prevention of human fungal infections. It is hoped that evidence from this research will provide additional evidence that passive immunity via M1G1 can be a potential candidate for use in clinical trials to treat patients with severe C. albicans infections.

CSULB Acknowledgement I would like to thank the Howard Hughes Medical Institute for providing the grants necessary for completing this project. I would like to thank my mentor Dr. Zhang for allowing me to work on this project and for providing the laboratory for the experiments.